SENSEX    32424.1       223.51    |    NIFTY    9580.3       90.20 FAQ    |    Feedback
Gainers & Losers Value & Volume Toppers 52 Weeks High/Low Advances & Declines
New High-Low
Pre-Session Mid-Session End-Session Other Markets Market Beat Stock Alert
Hot Pursuit Foreign Markets Economy News Corporate News Corporate Results
Detailed Quotes Board of Directors Balance Sheet Profit & Loss Quarterly Results Historical Price
Financial Ratios Company Background Technical Chart
Announcements Book Closure Board Meetings Bonus Issues Rights Issues
De-Listed Shares Name Change Split of Face Value Market Turnover
FII Investments MF Investments ADR Prices World Indices
Forthcoming IPOs
Open IPOs
Closed IPOs
New Listing
Basis Of Allotment Draft Prospectus New Issue Monitor
Get Quotes
Value Toppers Advances & Declines Ticker Spot
Ticker Futures Closing Price Technical Chart Commodity News MCX Currency Futures
Get Quotes NIFTY Futures Top Traded Value Top Quantity Most Active Contracts
FII Statistics Daily Settlement Price List of Underlyings Put Call Ratio Derivative Summary
All Index Futures Top Gainers Top Losers Most Active Put Most Active Call
Highest in OI Lowest in OI Increase in OI Decrease in OI
Hot Pursuit
Scrips, which has significant changes during the market hours for last one week.
Info Edge (India) venture fund invests in e-sports platform, telehealth firm
22-May-20   13:04 Hrs IST

Fanbuff Esports India operates e-sports community engagement platform Fanclash, and the Intellihealth Solutions operates telehealth platform Truemeds.

The IE Venture Fund will acquire 3,077 series seed compulsorily convertible preference shares at a face value of Rs 10 and a premium of Rs 11,364.70. The aggregate shareholding of IE Venture Fund I, post this investment, in Fanclash would be 20% on a fully converted & diluted basis.

Fanclash is an online e-sports focused engagement and community platform. E-sports fans can watch, play, follow various games like Free Fire, PUBG, Counter Strike and engage with their favorite esports players and streamers on the platform. Fanclash's vision is to become the go-to platform for e-sports fans.

The investment will help support Fanclash to grow its business in India, Info Edge said in a filing.

Meanwhile, IE Venture Fund I will acquire 24,980 series seed compulsorily convertible preference shares having face value of Rs 10 each at a premium of Rs 1,468.79. The aggregate shareholding of IE Venture Fund I, post this investment, in Truemeds would be 17.80% on a fully converted & diluted basis.

Truemeds which was incorporated on 1 February 2019 is a tele-health platform focused on selling top company traded generics/substitute medicines to consumers. Its telemedicine platform of doctors advises consumers about substitute medicines (offered by top pharma companies but at much cheaper costs) which could significantly reduce cost of their medical bills. Truemeds reported an unaudited turnover of Rs 1 crore for the 2019-'20 financial year, per Info Edge's filing.

On a consolidated basis, Info Edge (India) reported net loss of Rs 59.85 crore in Q3 December 2019 compared with net profit of Rs 331.78 crore in Q3 December 2018. Net sales rose 15.5% to Rs 335.06 crore in Q3 December 2019 over Q3 December 2018.

Info Edge (India) runs leading internet businesses like,, and The company also owns Quadrangle and Naukri Gulf. Info Edge has made significant strategic investments into emerging internet companies -,,,,

Shares of Info Edge (India) dropped 3.03% at Rs 2,377.45. The scrip hovered in the range of Rs 2,370 to Rs 2,432.15 so far.

Powered by Capital Market - Live News

Europe (EUR) 1.00 0.90 83.40 1.11
United Kingdom (GBP) 1.11 1.00 92.62 1.23
India (INR) 0.01 0.01 1.00 0.01
United States (USD) 0.90 0.81 75.11 1.00
Commodities << ALL Commodities
 Market News << ALL News
   Disclaimer   |   BSE Disclosure  |   Privacy Policy   |   Investor Protection   |   Inactive Account
Feedback   |   PMLA Policy   |   Risk Management Policy   |   Insider Trading   
   Investor Grivenances   |   Investor Complaints   |   Rules And Regulations   |   Broker Norms   |   Terms of Use SEBI Registration No : INZ000267132   |   BSE Clearing No : 333   
   Copyright © 2011 All rights reserved by Jaysukhlal Jagjivan Stock Broking Pvt.Ltd Designed, Developed & Powered By CMOTS INFOTECH (ISO 9001:2015 certified)